mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.5 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.5 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.5 |